ASTRAZENECA ENTERS MULTI-COLLABORATIVE PARTNERSHIP TO TREAT TYPE 2 DIABETES
DEC 15, 2020 @ 5.05PM
To establish a holistic approach to treating type 2 diabetes in Malaysia, AstraZeneca enters a multi-collaborative partnership with Tricog Health for the provision of AI diagnostics technology, and with tertiary care centres – Sunway Medical Centre, Sunway Medical Centre Velocity, and Cardiac Vascular Sentral Kuala Lumpur (CVSKL) - for early-stage diagnostics screening. This collaboration was formalised by a signing ceremony between AstraZeneca and all four parties.
“At AstraZeneca, we recognise the burden of type 2 diabetes on emerging markets and yet awareness levels remains limited. By embedding early disease management of long-term risks in the primary care setting, we can delay complications and ensure early diagnosis and referral, ultimately improving the standard of care for people living with type 2 diabetes,” said Dr Sanjeev Panchal, Country President, AstraZeneca Malaysia.
“By establishing a holistic approach and integrating advanced technologies that allow for early diagnostics and treatment into the patient pathway, we can develop the primary care ecosystem, minimise the cardio-renal risks related to type 2 diabetes and save more lives,” Dr Sanjeev further stated.
'Take Care of Me' clinical management model
A key component of the 'Take Care of Me' programme is the registry – a data-generation initiative which assesses the increased susceptibility of cardio-renal risks in diabetes patients at the clinical level. This enables primary care physicians to identify, prevent and treat comorbidities at an early stage.
In addition to the data registry, the multi-collaborative initiative will bring advanced AI technologies to the healthcare ecosystem in Malaysia by integrating data and diagnostic support solutions into the patient journey, starting with three primary care clinics - Poliklinik Shaik, Kota Kemuning; Klinik Seri Indah, Selayang Jaya; and Klinik Wong Singh, Selayang Jaya. Over the next three years, AstraZeneca plans to expand the number of clinics to 15, with an aim to diagnose over 6,000 patients.
Diabetic patients can opt to visit any of the three partner clinics where early screening tests for their blood sugar level (HbA1c), lipid profile and albumin-creatinine ratio (ACR) will be conducted. Here, Abbott’s Afinion system will support the primary care physicians and dedicated 'Take CaRe of Me' nurses will be on hand to profile and identify high-risk patients more effectively.
Once high-risk patients are identified, they will be referred to either one of the three partner tertiary care centres – Sunway Medical Centre, Sunway Medical Centre Velocity, and CVSKL – where they will be assessed by a specialist and undergo further testing using an Echocardiogram. With the support of AI technology from Tricog Health, the results are further evaluated to provide the specialists with insights for their treatment plan. The tertiary care centre support plays a vital role in achieving a cohesive end-to-end solution for patients.
The culture of colourism: The obsession with lighter skin tones driving opportunities in the skin lighteners market
Arson, animal cruelty and lack of remorse - traits of personality disorders to look out for in a person
University Malaya Medical Centre inks deal to make Uniportal VATS more affordable for lung cancer patients
Digital Health Malaysia takes health transformation to new heights with fourth telemedicine conference
Roche launch Perjeta - Herceptin combination, a post surgery treatment for early breast cancer (eBC)
Keytruda with chemotherapy to be the first line of treatment for patients with advanced lung cancer
33% below 15 exposed to sexual intercourse, at higher risk of developing cervical cancer says oncologist
Breast cancer survivor emphasizes on monthly self-examination, says no alternative therapy, magic pill for cure